Avantor Investor Conference Presentation Deck

Annual EPS growth expected to continue at mid-teens rate $0.10 FY17 Navantor™ ADJUSTED EPS¹ 100% CAGR $0.36 FY18 $0.58 1. Adjusted net income divided by 642.7M outstanding shares 2. FY20 consensus estimates FY19 $0.84 EPS GROWTH FY20E² LOOKING AHEAD Strong operational performance (EBITDA growth 1.5-2X sales growth) Tailwinds from 2020 refinancing Efficient tax structuring ... potential M&A creates upside 39th Annual J.P. Morgan Healthcare Conference 15

View entire presentation